Background Mesenchymal stem cells (MSCs) commonly affect idiopathic pulmonary fibrosis
(IPF) through the epithelial-mesenchymal transition (EMT) process. And exosomes of MSCs …

Background Previous reports have identified that human bone marrow mesenchymal stem
cell-derived extracellular vesicles (BMSC-EVs) with their cargo microRNAs (miRNAs) are a …

Idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease, usually leads to an
irreversible distortion of the pulmonary structure. The functional roles of bone marrow …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible
lung disease characterized by pulmonary fibrosis and lung dysfunction, ultimately leading to …

Objective Researchers have investigated miR-130b-3p in lung disease pathology, such as
lung fibrosis. The present study was performed to elucidate the miR-130b-3p-involved …

Idiopathic pulmonary fibrosis (IPF) is a chronic pulmonary fibrosis disease that is fatal.
Mesenchymal stem cells (MSCs)-secreted exosomes (exos) have been linked to improving …

Pulmonary fibrosis (PF) is a severe respiratory disease caused by lung microenvironment
changes. TGF-β/Smad3 signaling pathway plays a critical role in the fibrotic process …

Endothelial-to-mesenchymal transition (EndMT), the process by which endothelial cells lose
their characteristics and acquire mesenchymal phenotypes, participates in the pathogenic …

Idiopathic pulmonary fibrosis (IPF) is a prototype of chronic, progressive, and fibrotic lung
disease with high morbidity and high mortality. Menstrual blood‐derived stem cells …

Background: Silicosis is one of the most prevalent and fatal occupational diseases
worldwide, with unsatisfactory clinical outcomes. This study aimed to investigate the …